论文信息 - Transient Signal Intensity Enhancement in the Amniotic Fluid After Administration of a Macrocyclic Gadolinium Chelate to a Pregnant Woman

Transient Signal Intensity Enhancement in the Amniotic Fluid After Administration of a Macrocyclic Gadolinium Chelate to a Pregnant Woman

Since their implementation in clinical routine, little is known on the pharmacokinetics and effects of gadolinium (Gd) chelates on fetuses. Two experimental studies have reported the presence of Gd chelates in the amniotic fluid of gravid mice and macaques 24 hours after intravenous administration. We describe the case of a 27-week pregnant patient who underwent uterine magnetic resonance imaging (MRI) examinations after a cardiac MRI with Gd-chelate injection.

E. Lancelot | N. Siauve | J. Laissy | A. Dossier

[1] Stefan A Reinsberg,et al. Dynamic Contrast-Enhanced MRI. , 2018, Methods in molecular biology.

[2] E. Lancelot. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion , 2016, Investigative radiology.

[3] M. Schabel,et al. Gadolinium Chelate Contrast Material in Pregnancy: Fetal Biodistribution in the Nonhuman Primate. , 2015, Radiology.

[4] P. Sundgren,et al. Is administration of gadolinium‐based contrast media to pregnant women and small children justified? , 2011, Journal of magnetic resonance imaging : JMRI.

[5] C. Cuénod,et al. Maternofetal pharmacokinetics of a gadolinium chelate contrast agent in mice. , 2011, Radiology.

[6] G. Wolf,et al. Magnetic Resonance Imaging of the Placenta in Rhesus Monkeys, Macaca mulatta , 1988, Journal of medical primatology.